X Yan, H Duan, Y Ni, Y Zhou, X Wang, H Qi… - International Journal of …, 2022 - Elsevier
Background Clinical benefit of neoadjuvant immunotherapy in resectable esophageal
squamous cell carcinoma (ESCC). remains unclear. This study evaluated the efficacy and …